ArticleFrontiers in oncology2025
Personalized diagnosis of radiation pneumonitis in breast cancer patients based on radiomics.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Improving the Prediction of Radiation Pneumonitis: Leveraging Radiomics and Dosiomics Within IDLSS Lung Subregions.Life (Basel, Switzerland) · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to identify CT-based radiomic alterations associated with radiation pneumonitis (RP) and to evaluate the feasibility of machine learning classifiers for personalized RP diagnosis in breast cancer patients using these radiomic signatures. Methods: A total of 146 planning CT scans (pre- and post-radiotherapy) from 73 breast cancer patients with confirmed RP were retrospectively analyzed. The entire lung was delineated as the region of interest (ROI), and 1,834 radiomic features were extracted using PyRadiomics. Feature selection was performed sequentially using the Mann-Whitney U-test (p < 0.05), Spearman's rank correlation (|ρ| < 0.9), and least absolute shrinkage and selection operator (LASSO). Eight classifiers [logistic regression (LR), support vector machine (SVM), K-nearest neighbor (KNN), random forest (RF), Extra Tree (ET), XGBoost, LightGBM, and multilayer perceptron (MLP)] were trained and evaluated using accuracy, area under the receiver operating characteristic curve (AUC) with 95% confidence intervals, sensitivity, and specificity. Results: In the independent test cohort, LR achieved the highest performance [accuracy 0.897, AUC 0.929 (95% CI, 0.838-1.000), sensitivity 0.786, and specificity 1.000]. LightGBM and MLP also exhibited robust discrimination with AUC values of 0.855 (95% CI, 0.719-0.990) and 0.848 (95% CI, 0.705-0.991), respectively. Five texture-oriented and four first-order features were retained, underscoring the importance of texture-focused extractors [wavelet and local binary pattern (LBP)]. Conclusion: CT-derived radiomic signatures combined with machine learning classifiers enable the accurate detection of RP in breast cancer patients. Texture-oriented feature selection enhances model discrimination, providing potential for the personalized diagnosis of RP in breast cancer patients and adaptive treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.